Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Elissa S. Cote currently holds 75,000 shares of Vistagen Therapeutics, Inc. (VTGN), valued at approximately $0. This represents their equity stake as Chief Corp Development Officer.
Based on SEC Form 4 filings, Elissa S. Cote has been a net neutral trader of VTGN stock. They have purchased $0 and sold $0 worth of shares.
Elissa S. Cote's most recent insider trade was on Apr 7, 2026, when they sold 75,000 shares at $0.00 per share.
Elissa S. Cote serves as Chief Corp Development Officer at Vistagen Therapeutics, Inc. (VTGN). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Elissa S. Cote holds the position of Chief Corp Development Officer at Vistagen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Elissa S. Cote has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Elissa S. Cote was on Apr 7, 2026, when they purchased $0 worth of VTGN shares. This transaction involved 75,000 shares at N/A per share.
Elissa S. Cote currently owns 75,000 shares of Vistagen Therapeutics, Inc. (VTGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Elissa S. Cote's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Elissa S. Cote has 1 Form 4 filings on record as an insider at Vistagen Therapeutics, Inc..
Set alerts for Elissa S. Cote and 40,000+ other insiders.